83 related articles for article (PubMed ID: 1855900)
41. Strategies for prevention and control of hepatitis B and hepatocellular carcinoma.
Sobeslavsky O
IARC Sci Publ; 1984; (63):271-8. PubMed ID: 6100274
[TBL] [Abstract][Full Text] [Related]
42. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
Kuang SY; Lekawanvijit S; Maneekarn N; Thongsawat S; Brodovicz K; Nelson K; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):380-4. PubMed ID: 15734961
[TBL] [Abstract][Full Text] [Related]
43. Epidemiology of hepatitis B in Canadian blood donors.
O'Brien SF; Xi G; Fan W; Yi QL; Fearon MA; Scalia V; Goldman M
Transfusion; 2008 Nov; 48(11):2323-30. PubMed ID: 18647366
[TBL] [Abstract][Full Text] [Related]
44. Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer.
Groopman JD; Wang JS; Scholl P
Can J Physiol Pharmacol; 1996 Feb; 74(2):203-9. PubMed ID: 8723033
[TBL] [Abstract][Full Text] [Related]
45. The development of hepatocellular cancer in humans.
Kew MC
Cancer Surv; 1986; 5(4):719-39. PubMed ID: 3040242
[TBL] [Abstract][Full Text] [Related]
46. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice.
Ghebranious N; Sell S
Hepatology; 1998 Feb; 27(2):383-91. PubMed ID: 9462635
[TBL] [Abstract][Full Text] [Related]
47. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
48. Viral hepatitis in Bucharest.
Paquet C; Babes VT; Drucker J; Sénémaud B; Dobrescu A
Bull World Health Organ; 1993; 71(6):781-6. PubMed ID: 8313496
[TBL] [Abstract][Full Text] [Related]
49. Aflatoxin exposure in human populations: measurements and relationship to cancer.
Groopman JD; Cain LG; Kensler TW
Crit Rev Toxicol; 1988; 19(2):113-45. PubMed ID: 3069332
[No Abstract] [Full Text] [Related]
50. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.
Wang JS; Qian GS; Zarba A; He X; Zhu YR; Zhang BC; Jacobson L; Gange SJ; Muñoz A; Kensler TW
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):253-61. PubMed ID: 8722216
[TBL] [Abstract][Full Text] [Related]
51. Aflatoxins: data on human carcinogenic risk.
Bosch FX; Peers F
IARC Sci Publ; 1991; (105):48-53. PubMed ID: 1855900
[TBL] [Abstract][Full Text] [Related]
52. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA
Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933
[TBL] [Abstract][Full Text] [Related]
53. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
54. A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention.
Wild CP; Montesano R
Cancer Lett; 2009 Dec; 286(1):22-8. PubMed ID: 19345001
[TBL] [Abstract][Full Text] [Related]
55. Etiology of hepatocellular carcinoma in Africa.
Olweny CL
IARC Sci Publ; 1984; (63):89-95. PubMed ID: 6100289
[TBL] [Abstract][Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
